Kaposi Sarcoma Treatment Market
Patients receiving organ transplants are more susceptible to Kaposi sarcoma due to the rising incidence of the disease and the expanding number of patients receiving these operations. HHV-8 infection is quite common in people whose immune systems have been compromised by AIDS or medications taken after organ transplant surgery. Immunosuppressive medications are administered to organ transplant recipients to stop their bodies from rejecting the graft, which makes them more vulnerable to Kaposi Sarcoma Treatment Market infection. These patients' risk rate increases by over 100 times greater than that of the general population as a result of long-term usage of these drugs.
